Key Insights

Highlights

Treatment Research

1 treatments under study, led by Oxaliplatin S1 Radiotherapy

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01106066Phase 1/2TerminatedPrimary

Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT

Showing all 1 trials

Research Network

Common Treatments

  • Oxaliplatin S1 Radiotherapy1

Active Sponsors

  • Samsung Medical Center1

Top Investigators

Related Conditions

  • Phase Ii To Assess The Pathologic Cr Rate And Feasibility Following Neoadjuvant Chemoradiation Therapy With S1oxaliplatin1

Activity Timeline